News
Nasdaq listing aims to increase market visibility and global liquidity opportunities as BioStem advances its commercial and clinical initiatives amid record revenue growth

30 September 2024

News
Renowned Biotech Leader to Contribute Expertise in Neuroscience and Therapeutics Development

30 September 2024

News
BOCA RATON, FL, September 27, 2024 - PRISM MediaWire - SMC Entertainment, Inc. ("SMC" or the "Company") (OTC: SMCE), an incubator company focused on acquisition and support of commercialized services and technology (Fintech) companies, announced today that Globe Small Ca...

27 September 2024

News
Cutting-Edge Gear to Empower Athletes in the Ultimate Endurance Challenge

26 September 2024

News
Strategic Acquisition of Southwest Financial Services Creates a Dynamic New Fintech Subsidiary for Project Financing and Lending Solutions

26 September 2024

News
Miami, Florida, September 25, 2024 - PRISM MediaWire - LuxUrban Hotels Inc. (Nasdaq: LUXH), a hospitality company that leases entire hotels on a long-term basis, manages these hotels, and rents out rooms to guests in the properties it leases, today announced its financia...

25 September 2024

Pharmaceutical
NEW YORK, September 25, 2024 - PRISM MediaWire - PRISM MarketView presents an exclusive Q&A with Dr. Michael Chancellor, Co-founder and Chief Medical Officer of Lipella Pharmaceuticals, Inc. (Nasdaq: LIPO). In this interview, Dr. Chancellor provides insights into the...

25 September 2024

News
Conference Call and Webcast to be held on September 25, 2024 at 5:00 PM ET

25 September 2024

News
Global Leader Nears Final Testing Phase Which Could Lead to Long-Term Supply Agreements

25 September 2024

News
PITTSBURGH, Sept. 24, 2024 - PRISM MediaWire - Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) (“Lipella” or the “Company”), a clinical-stage biotechnology company focused on addressing serious diseases with significant unmet needs, today announced an update on its ongoing m...

24 September 2024

7
8
9
10
11
12
13
We use cookies to run our website, analyze your use of our services, manage your online preference & personalize ad content. By accepting our cookies, you’ll get relevant content and social media features, personalized ads, and an enhanced browsing experience. To manage your choices, click „Cookie Settings”. Necessary cookies are required for the core website functionality and cannot be rejected. For more information, see our Cookie Policy.
Cookie settings
Cookies used on the site are categorized and below you can read about each category and allow or deny some or all of them, except for Necessary Cookies which are required to provide core website functionality. When categories that have been previously allowed are disabled, all cookies assigned to that category will be removed from your browser. You can see a list of cookies assigned to each category and detailed information on those cookies in the “Cookie Policy” tab.
Necessary cookies
Some cookies are required to provide core functionality. The website won't function properly without these cookies and they are enabled by default and cannot be disabled.
Preferences
Preference cookies enables the website to remember information to customize how the website looks or behaves for each user. This may include storing selected currency region, language or color theme.
Analytical cookies
Analytical cookies help us improve our website by collecting and reporting information on its usage.
Marketing cookies
Marketing cookies are used to track visitors across websites to allow publishers to display relevant and engaging advertisements. By enabling marketing cookies, you grant permission for personalized advertising across various platforms.